×
About 1,160 results

ALLMedicine™ Respiratory Syncytial Virus Infection Center

Research & Reviews  425 results

CD14 and related genes in respiratory morbidity after Respiratory Syncytial Virus infec...
https://doi.org/10.1093/infdis/jiac248
The Journal of Infectious Diseases; Gómez-Carballa A, Pischedda S et. al.

Jun 18th, 2022 - CD14 and related genes in respiratory morbidity after Respiratory Syncytial Virus infection.|2022|Gómez-Carballa A,Pischedda S,Rivero-Calle I,Montoto-Louzao J,Martinón-Torres F,|

Human Mobility and Droplet-Transmissible Pediatric Infectious Diseases during the COVID...
https://doi.org/10.3390/ijerph19116941
International Journal of Environmental Research and Publi... Ae R, Shibata Y et. al.

Jun 11th, 2022 - The study tested the hypothesis that human mobility may be a potential factor affecting reductions in droplet-transmissible pediatric infectious diseases (PIDs) during the coronavirus disease-2019 (COVID-19) pandemic mitigation period in 2020. An ...

Pranlukast treatment and the use of respiratory support in infants with respiratory syn...
https://doi.org/10.1371/journal.pone.0269043
PloS One; Kubota J, Takahashi S et. al.

May 28th, 2022 - In infants, respiratory syncytial virus (RSV) infection occasionally causes severe symptoms requiring respiratory support; however, supportive care is the primary treatment. This study compared the use of respiratory support among infants with RSV...

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
https://clinicaltrials.gov/ct2/show/NCT03656510

May 16th, 2022 - JNJ-53718678 is an investigational respiratory syncytial virus (RSV) specific fusion inhibitor and is under development for the treatment of RSV infection, which results in an upper and/or lower respiratory tract illness. The primary hypothesis of...

see more →

Guidelines  1 results

Updated guidance for palivizumab prophylaxis among infants and young children at increa...
https://doi.org/10.1542/peds.2014-1665
Pediatrics ,

Jul 30th, 2014 - Palivizumab was licensed in June 1998 by the Food and Drug Administration for the reduction of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV) in children at increased risk of severe disease. Since that time, ...

see more →

Clinicaltrials.gov  12 results

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
https://clinicaltrials.gov/ct2/show/NCT03656510

May 16th, 2022 - JNJ-53718678 is an investigational respiratory syncytial virus (RSV) specific fusion inhibitor and is under development for the treatment of RSV infection, which results in an upper and/or lower respiratory tract illness. The primary hypothesis of...

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults
https://clinicaltrials.gov/ct2/show/NCT04752644

Apr 1st, 2022 - A Phase 2a, Randomised, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Immunogenicity and Efficacy of the Recombinant MVA-BN®-RSV Vaccine against Respiratory Syncytial Virus Infection in the Virus Challenge Model in Healthy Adult P...

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Yea...
https://clinicaltrials.gov/ct2/show/NCT03334695

Jul 23rd, 2021 - The purpose of this study is to assess a trend for the prophylactic efficacy of a single dose of 1*10^11 virus particles (vp) of adenovirus serotype 26 respiratory syncytial virus pre-fusion F protein (Ad26.RSV.preF) administered intramuscularly t...

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection
https://clinicaltrials.gov/ct2/show/NCT03332459

Apr 13th, 2021 - RSV is a leading cause of lower respiratory tract disease in infants. The primary hypothesis is that treatment of RSV-infected infants/children with lumicitabine (also known as JNJ-64041575 or ALS-008176) will decrease subsequent wheezing/asthma c...

Respiratory Syncytial Virus Infection May be More Dangerous in Neonate
https://clinicaltrials.gov/ct2/show/NCT04531735

Aug 28th, 2020 - This single center cross-sectional study was conducted in University of Health Sciences Dr Behçet Uz Children's Hospital with a 400-bed tertiary care hospital in İzmir, Turkey, during the period of March 11 - April 30, 2020. This hospital is a ped...

see more →

News  25 results

Acid Suppressants Worsen Respiratory Symptoms in Infants
https://www.staging.medscape.com/viewarticle/927518

Mar 26th, 2020 - For children exposed to acid-suppressant medications, such as proton pump inhibitors and histamine 2 receptor antagonists, during their first year of life, the risk for recurrent wheeze at age 3 is significantly elevated, researchers warn. "We are...

FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children
https://www.mdedge.com/familymedicine/article/206884/pulmonary-infections/fuo-pneumonia-often-distinguishes-influenza-rsv?channel=39313
MDedge Infectious Disease; Bruce Jancin

Aug 22nd, 2019 - LJUBLJANA, SLOVENIA – Fever of unknown origin and pneumonia are two clinical features useful in distinguishing between influenza and respiratory syncytial virus infection as the cause of hospitalization in infants and young children, Cihan Papan,.

FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children
https://www.mdedge.com/infectiousdisease/article/206884/pulmonary-infections/fuo-pneumonia-often-distinguishes-influenza
Bruce Jancin

Aug 22nd, 2019 - LJUBLJANA, SLOVENIA – Fever of unknown origin and pneumonia are two clinical features useful in distinguishing between influenza and respiratory syncytial virus infection as the cause of hospitalization in infants and young children, Cihan Papan,.

VIDEO: Rapid influenza test obviates empiric antivirals
https://www.mdedge.com/chestphysician/article/150645/lung-cancer/video-rapid-influenza-test-obviates-empiric-antivirals
Mitchel L. Zoler, PhD, MDedge News

Oct 31st, 2017 - TORONTO – A test that only requires a maximum 2-hour wait for results was highly accurate at detecting influenza and respiratory syncytial virus infection in lung transplant patients, according to research presented at the CHEST annual meeting on.

Is Nebulized Hypertonic Saline More Effective for Bronchiolitis?
https://www.medscape.com/viewarticle/886314

Oct 10th, 2017 - Hypertonic Versus Normal Saline Nebulizer Treatments The goal of a recent study[1] was to evaluate whether nebulized hypertonic saline (3%) was more beneficial than nebulized normal saline (0.9%) in the treatment of infants presenting to the emerg...

see more →

Patient Education  1 results see all →